Form 4: Ingevity Corp President & CEO David H. Li Reports Acquisition of Shares and Stock Options
SEC Form 4
David H. Li, President & CEO of Ingevity Corp, reports the acquisition of common stock and stock options.
Summary
- On April 7, 2025, David H. Li, President & CEO of Ingevity Corp, reported transactions involving Ingevity Corp [NGVT] securities.
- Li acquired 86,669 shares of common stock and 31,516 shares of common stock.
- These shares were acquired at a price of $0.
- Following these transactions, Li directly owns 118,185 shares of Ingevity Corp common stock.
- Li also acquired 177,305 employee stock options with an exercise price of $31.73, exercisable starting April 7, 2026, and expiring on April 7, 2035.
- These options also vest ratably in four installments on April 7, 2026, 2027, 2028 and 2029.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares and options could be seen as a positive sign, but it's not definitively bullish.
Positives
- The acquisition of shares and stock options by the CEO could be interpreted as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The vesting schedules for the RSUs and stock options extend to 2029, suggesting a long-term commitment from the CEO.
Industry Context
Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. This filing is a routine disclosure required by the SEC.
Comparison to Industry Standards
- Stock option grants and RSU grants are common forms of executive compensation in publicly traded companies like Ingevity.
- Vesting schedules and exercise prices are typically structured to align executive incentives with long-term shareholder value creation.
- Companies like Ecolab, Sherwin-Williams, and PPG Industries also utilize similar compensation strategies for their executives.
Stakeholder Impact
- The transactions could influence investor sentiment regarding Ingevity Corp's prospects.
- Employees may view the CEO's stock ownership as a sign of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 04/07/2025 | Date of earliest transaction: Acquisition of common stock and stock options. |
| 04/07/2026 | First vesting date for RSUs and stock options. |
| 04/07/2027 | Second vesting date for RSUs and stock options. |
| 04/07/2028 | Third vesting date for RSUs. |
| 04/07/2029 | Fourth vesting date for RSUs and stock options. |
| 04/07/2035 | Expiration date for stock options. |
| 04/09/2025 | Date of Form 4 signature. |
Keywords
Ingevity Corp, David H. Li, Form 4, Stock Options, Common Stock, RSUs, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.